Guaiacol

Guaiacol

SCHEMBL678968

COc1ccccc1[O-].[Na+]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Guaiacol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 3/20 0.60
CA2 known ✓ P00918 3/20 0.60
CA12 known ✓ O43570 1/20 0.60
CA4 known ✓ P22748 1/20 0.60
PTGS1 known ✓ P23219 1/20 0.48
CA7 P43166 2/20 0.60
CA9 Q16790 2/20 0.60
CA14 Q9ULX7 1/20 0.60
ENPP2 Q13822 1/20 0.50
ORAI1 Q96D31 1/20 0.48
ORAI2 Q96SN7 1/20 0.48
ORAI3 Q9BRQ5 1/20 0.48
ALDH1A1 P00352 5/20 0.48
TDP1 Q9NUW8 2/20 0.48
TP53 P04637 2/20 0.48
TSHR P16473 1/20 0.48
ADRA2B P18089 1/20 0.48
APP P05067 1/20 0.46
MAPK1 P28482 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guaiacol SCHEMBL9363005 0.95 CA1 (0.60) CA1CA2CA7CA9CA12
Guaiacol SCHEMBL3289583 0.95 CA1 (0.60) CA1CA2CA7CA9CA12
Guaiacol SCHEMBL9419753 0.95 CA1 (0.60) CA1CA2CA7CA9CA12
Guaiacol SCHEMBL6063786 0.95 CA1 (0.60) CA1CA2CA7CA9CA12
Guaiacol SCHEMBL3288239 0.95 CA1 (0.60) CA1CA2CA7CA9CA12
Guaiacol SCHEMBL9192643 0.81 CA1 (0.44) CA1CA2CA7CA9CA12
1,2-Dimethoxybenzene SCHEMBL5308636 0.76 CA1 (1.00) CA1CA2CA7CA9CA12
1,2-Dimethoxybenzene SCHEMBL29351917 0.76 CA1 (1.00) CA1CA2CA7CA9CA12
1,2-Dimethoxybenzene SCHEMBL105872 0.76 CA1 (1.00) CA1CA2CA7CA9CA12
1,2-Dimethoxybenzene SCHEMBL9793057 0.74 CA1 (0.93) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054365-A2 METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES Uniban - Universidade Bandeirante De São Paulo (BR) 2009-05-06 EP claimed
WO-2008003155-A2 METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES UNIBAN - UNIVERSIDADE BANDEIRANTE DE SÃO PAULO - ACADEMIA PAULISTA ANCHIETA S/C LTDA (BR) 2008-01-10 WO claimed
EP-3535243-B1 SUBSTITUTED 9H-XANTHEN-9-ONE, 9H-THIOXANTHEN-9-ONE AND ACRIDIN-9(10H)-ONE DERIVATIVES AND RELATED COMPOUNDS CSF-1R INHIBITORS FOR THE TREATMENT OF CANCER AUCKLAND UNISERVICES LTD (NZ) 2021-12-15 EP disclosed
US-11028064-B2 Tricyclic heterocyclic derivatives and uses thereof AUCKLAND UNISERVICES LIMITED (NZ) 2021-06-08 US disclosed
US-10968313-B2 Amine polymer and preparation method and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2021-04-06 US disclosed
EP-3385299-B1 AMINE POLYMER AND PREPARATION METHOD AND USE THEREOF. CHINA PETROLEUM & CHEM CORP (CN) 2020-11-04 EP disclosed
US-20190276423-A1 TRICYCLIC HETEROCYCLIC DERIVATIVES AND USES THEREOF AUCKLAND UNISERVICES LIMITED (NZ) 2019-09-12 US disclosed
EP-2574187-B1 SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME AMYRIS INC (US) 2019-09-11 EP disclosed
EP-3535243-A2 TRICYCLIC HETEROCYCLIC DERIVATIVES AND USES THEREOF Auckland Uniservices Limited (NZ) 2019-09-11 EP disclosed
US-20180362710-A1 AMINE POLYMER AND PREPARATION METHOD AND USE THEREOF RESEARCH INSTITUTE OF PETROLEUM PROCESSING, SINOPEC (CN) 2018-12-20 US disclosed
EP-3385299-A1 AMINE POLYMER AND PREPARATION METHOD AND USE THEREOF. China Petroleum & Chemical Corporation (CN) 2018-10-10 EP disclosed
US-4116891-A FROM CYCLIC HALOPHOSPHAZENES, LEWIS ACID ARMSTRONG CORK COMPANY (US) 1978-09-26 US disclosed
US-4110421-A Catalytic process for the preparation of phosphazene polymers ARMSTRONG CORK COMPANY (US) 1978-08-29 US disclosed
US-4108805-A FIRE RETARDANT ARMSTRONG CORK COMPANY (US) 1978-08-22 US disclosed
US-4107108-A FOAMED FIRE-RETARDANT ARMSTRONG CORK COMPANY (US) 1978-08-15 US disclosed
US-4073824-A FIRE RETARDANT, NONSMOKING ARMSTRONG CORK COMPANY (US) 1978-02-14 US disclosed
US-4055545-A SOLID CARBOXYLIC ACID ARMSTRONG CORK COMPANY (US) 1977-10-25 US disclosed
US-4055520-A FIRE RETARDANT ARMSTRONG CORK COMPANY (US) 1977-10-25 US disclosed
US-4055523-A FIRE RETARDANT ARMSTRONG CORK COMPANY (US) 1977-10-25 US disclosed
US-4026838-A INCORPORATING A SOLID CARBOXYLIC ACID ARMSTRONG CORK COMPANY (US) 1977-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11028064-B2 Tricyclic heterocyclic derivatives and uses thereof CSF3R, CSF1R, FLT3 CA1 2186/4885CA2 2606/4885CA12 2779/4885
US-20190276423-A1 TRICYCLIC HETEROCYCLIC DERIVATIVES AND USES THEREOF CSF3R, CSF1R, FLT3 CA1 2186/4885CA2 2606/4885CA12 2779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.